- Home
- ESGRO vs VCEL Comparison
ESGRO vs VCEL Comparison
Compare ESGRO & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESGRO
- VCEL
- Stock Information
- Founded
- ESGRO N/A
- VCEL 1989
- Country
- ESGRO Bermuda
- VCEL United States
- Employees
- ESGRO 790
- VCEL N/A
- Industry
- ESGRO Property-Casualty Insurers
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ESGRO Finance
- VCEL Health Care
- Exchange
- ESGRO Nasdaq
- VCEL Nasdaq
- Market Cap
- ESGRO N/A
- VCEL 2.1B
- IPO Year
- ESGRO N/A
- VCEL 1997
- Fundamental
- Price
- ESGRO $19.21
- VCEL $40.62
- Analyst Decision
- ESGRO
- VCEL Strong Buy
- Analyst Count
- ESGRO 0
- VCEL 8
- Target Price
- ESGRO N/A
- VCEL $62.00
- AVG Volume (30 Days)
- ESGRO N/A
- VCEL 427.8K
- Earning Date
- ESGRO N/A
- VCEL 07-31-2025
- Dividend Yield
- ESGRO N/A
- VCEL N/A
- EPS Growth
- ESGRO N/A
- VCEL 521.85
- EPS
- ESGRO N/A
- VCEL 0.05
- Revenue
- ESGRO N/A
- VCEL $238,541,000.00
- Revenue This Year
- ESGRO N/A
- VCEL $23.03
- Revenue Next Year
- ESGRO N/A
- VCEL $24.52
- P/E Ratio
- ESGRO N/A
- VCEL $777.12
- Revenue Growth
- ESGRO N/A
- VCEL 14.80
- 52 Week Low
- ESGRO N/A
- VCEL $37.39
- 52 Week High
- ESGRO N/A
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- ESGRO 34.68
- VCEL 44.61
- Support Level
- ESGRO $19.11
- VCEL $39.39
- Resistance Level
- ESGRO $20.58
- VCEL $43.57
- Average True Range (ATR)
- ESGRO 0.33
- VCEL 1.60
- MACD
- ESGRO -0.11
- VCEL -0.24
- Stochastic Oscillator
- ESGRO 41.95
- VCEL 29.43
About ESGRO Enstar Group Limited Depository
Enstar Group Ltd is a (re)insurance group that offers capital release solutions through its network of group companies. It seeks to create value by managing (re)insurance companies and portfolios of (re)insurance and other liability businesses in run-off and striving to generate an attractive risk-adjusted return from its investment portfolio. Its operations are through two reportable segments: Run-off segment and Investments segment.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.